Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Benzodiazepine Detoxification Using Flumazenil
NCT00000246Phase 2Completed
- Sponsor
- Yale University
- Start
- Jan 1993
- Primary completion
- Dec 1994
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 2 trial of flumazenil in benzodiazepine withdrawal syndrome (BWS), sponsored by Yale University. Primary endpoint: Benzodiazepine withdrawal severity. Started Jan 1993; status: completed.
02
Drugs
flumazenil
03
Conditions
benzodiazepine withdrawal syndrome (BWS)
Beyond the preview
Go deeper on NCT00000246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000246.